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All class II aminoacyl-tRNA synthetases (aaRSs) are
known to be active as functional homodimers, homo-
tetramers, or heterotetramers. However, multimeric
organization is not a prerequisite for phenylalanyla-
tion activity, as monomeric mitochondrial phenyla-
lanyl-tRNA synthetase (PheRS) is also active. We
herein report the structure, at 2.2 A˚ resolution, of
a human monomeric mitPheRS complexed with
Phe-AMP. The smallest known aaRS, which is, in
fact, 1/5 of a cytoplasmic analog, is a chimera of
the catalytic module of the a and anticodon binding
domain (ABD) of the bacterial b subunit of (ab)2
PheRS. We demonstrate that the ABD located at
the C terminus of mitPheRS overlaps with the accep-
tor stem of phenylalanine transfer RNA (tRNAPhe) if
the substrate is positioned in a manner similar to
that seen in the binary Thermus thermophilus com-
plex. Thus, formation of the PheRS-tRNAPhe complex
in human mitochondria must be accompanied by
considerable rearrangement (hinge-type rotation
through 160) of the ABD upon tRNA binding.
INTRODUCTION
Aminoacyl-tRNA synthetases (aaRSs) play a crucial role in the
translation of the genetic code by means of covalent attachment
of amino acids to their cognate tRNAs. Based on the architecture
of the catalytic sites and the tRNA recognition mode, aaRSsmay
be divided into two classes (Eriani et al., 1990). Class I aaRSs are
primarily active as functional monomers, while all class II aaRSs
whose structures have been solved to date are known to function
as dimers or tetramers.
In eukaryotes, protein synthesis occurs not only in the cyto-
plasm, but also inmitochondria (mit) and chloroplasts. Themam-
malian mit translation system has dual origins, with a mit DNA
encoded set of 22 tRNAs and two ribosomal RNAs (Zifa et al.,
2007). In general, all other translational factors are encoded in
the nucleus and imported into the organelle posttranslationally.
It appears that, despite the bacterial origins, the mit translational
apparatus markedly deviates from its bacterial ancestors.Structure 16Only limited information on the tRNA recognition and aminoa-
cylation properties of mammalian mit aaRSs is so far available
(Sissler et al., 2005). The specific activities of several mammalian
mit aaRSs were shown to be about 20- to 400-fold lower than
those observed for homologous aaRSs of both prokaryotic and
eukaryotic-cytoplasmic origin (Sissler et al., 2005). Furthermore,
recent findings indicate that at least 100 known human genetic
diseases originate from mutations in the mitochondrial transla-
tional machinery (Jacobs and Turnbull, 2005; Wittenhagen and
Kelley, 2003). A deeper insight into the unique characteristics
of the mit aaRSs is therefore critical if we are to clarify the molec-
ular mechanisms of such diseases.
Structural studies of the bacterial PheRS (Mosyak et al., 1995)
have revealed the nature of the PheRS (ab)2 subunit organiza-
tion. The heterotetrameric subunit organization of both prokary-
otic and eukaryotic cytoplasm PheRSs is markedly conserved in
all known species. Neither the a or b monomers nor the a2 or b2
dimers manifest catalytic activity in tRNA aminoacylation (Bob-
kova et al., 1991). The a subunit domains create a catalytic mod-
ule (CAM) and, together with the N-terminal coiled-coil domain,
are directly involved in aminoacylation and tRNAPhe binding,
whereas the major function of the b subunit consists in the rec-
ognition and binding of tRNAPhe (Goldgur et al., 1997). Structural
analysis of the bacterial PheRS complexed with tRNAPhe further
demonstrated that one tRNAPhe molecule interacts with all four
subunits of the enzyme, thus accounting for the enzyme’s activ-
ity as a functional (ab)2 dimer. Remarkably, whereas the amino-
acylation of a given tRNA is catalyzed by the a subunit of one ab
heterodimer, its anticodon is recognized by the ABD of the b*
subunit, which belongs to the symmetry-related heterodimer.
Human mitochondrial PheRS (mitPheRS) is the smallest
known nuclear-encoded synthetase exhibiting homology to bac-
terial PheRSs. The total length of the bacterial enzyme (from
Thermus thermophilus) is made up of 2270 residues (Mosyak
et al., 1995), whereas the mature mitPheRS is a single-chain en-
zyme consisting of 415 amino acids and, in fact, is a chimera of
the catalytic a subunit and the B8-like domain from the b subunit
of bacterial PheRS (Bullard et al., 1999).Whereas, in bacterial cy-
toplasmic PheRS, the anticodon arm of tRNAPhe is sandwiched
between the N-terminal coiled-coil of the a subunit and the
B8*-domain of the b* subunit, it is of considerable interest to re-
veal the mode of tRNA binding and aminoacylation by the mono-
meric class II enzyme.We report here a 2.2 A˚ resolution structure
of human monomeric mitPheRS complexed with Phe-AMP.
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tRNA Triggers Rearrangement of ABD in mitPheRSthe peculiar conformational changes in the environment sur-
rounding the adenylate binding area, which can effect on the
structural guidelines of phenylalanine activation. The modeled
mitPheRS-tRNAPhe complex shows that mitPheRS, in the native
(‘‘close’’) state, renders recognition of the anticodon of tRNA im-
possible, while keeping the acceptor end of the tRNA within the
active site of the enzyme. We further discuss the necessity of
significant conformational rearrangement of the ABD upon
mitPheRS-tRNAPhe complex formation.
RESULTS
Overall Structure of mitPheRS
Eukaryotic mitPheRSs from various sources exist as a monomer
under native conditions (Bullard et al., 1999; Levin et al., 2007;
Sanni et al., 1991). The gel filtration experiments with recombi-
nant, untagged human mitPheRS indicate that the protein has
an apparent molecular mass of 45 kDa. This value is in good
agreement with the theoretical mass (49.6 kDa) of the mono-
meric enzyme. To provide evidence that human mitPheRS also
functions as amonomer in the presence of tRNAPhe, we analyzed
the apparent molecular mass of the binary mitPheRS$tRNAPhe
complex. The complex was eluted from a gel filtration column
at a retention volume corresponding to a molecular mass of
71 kDa (see Figure S1 available online). This suggests that
the complex is formed by monomeric mitPheRS and tRNAPhe.
MitPheRS was purified and crystallized in complex with phe-
nylalanine and ATP, as previously described (Levin et al.,
2007). The crystals diffract to 2.2 A˚ resolution and belong to
the space group P212121, with unit cell parameters of a = 54.9
A˚, b = 90.0 A˚, c = 96.0 A˚. Crystals contain a single molecule in
the asymmetric unit. Data collection and structure refinement
statistics are given in Table 1. The final atomic model, refined
at 2.2 A˚ resolution, includes 405 amino acid residues, 221 water
molecules, and a magnesium ion. Residues 1–10 from the
N terminus are disordered, and were not detected in the electron
density maps. All 4 and c angles lie in the allowed region of the
Ramachandran plot, with 91.3% in the most favored region.
Human mitPheRS consists of four major parts: the N-terminal
region (residues 1–47), the catalytic domain (residues 48–289),
the linker region (residues 290–322), and the C-terminal domain
(residues 323–415) (Figure 1A). The N-terminal extension is
composed of an antiparallel b hairpin, followed by a short helical
fragment, and a coiled region. The linker region is composed of
a helix and a long, extended stretch of amino acids connected to
the C-terminal domain. The C-terminal domain (B8-like) displays
a typical RNA recognition fold (RRM) formed by the four-
stranded antiparallel b sheet, with two helices packed against it.
Three signature motifs of class II aaRSs have been revealed in
the human mitochondrial enzyme (Bullard et al., 1999). Whereas
the characteristic supersecondary structure of all three motifs
manifests itself very clearly, only motif 3 displays a high degree
of sequence similarity with those of bacterial PheRSs
(Figure 1B). Motif 2 shares 50% identity with the sequence of
the corresponding fragment of the T. thermophilus PheRS a sub-
unit. Surprisingly, motif 1, characterized by a relatively long a he-
lix followed by a b strand, and implicated in interface formation in
class II dimers and tetramers, also constitutes the inherent struc-
tural motif of the monomeric enzyme. Notably, the motif 1 region1096 Structure 16, 1095–1104, July 2008 ª2008 Elsevier Ltd All righof homotetrameric AlaRS is also not involved in any intermolec-
ular interactions (Swairjo et al., 2004). A general remark that can
be made concerning intersubunit communication within sub-
class IIc is that the role played by motif 1 is not limited to forma-
tion of the four-helix bundle, but, rather, is more versatile, and
bears additional functional loads. Human mitPheRS is also
characterized by large insertion into the amino acid sequence
between motifs 2 and 3, thus creating a structural fragment
(residues 165–202), the functional role of which remains to be
seen.
Comparison of Human mitPheRSs
with Other Class IIc aaRSs
Until recently, class II aaRSs have been subdivided into three
subclasses—IIa, IIb, and IIc—which possess structurally distinct
tRNA ABDs (Cusack, 1995; O’Donoghue and Luthey-Schulten,
2003). While subclasses IIa and IIb are associated with homodi-
meric proteins, subclass IIc, until recent times, included the only
heterotetrameric protein, PheRS. Recently, however, subclass
IIc has been replenished by homotetrameric AlaRS and two
unique aaRSs: SepRS and PylRS (Fukunaga and Yokoyama,
2007; Kamtekar et al., 2007; Kavran et al., 2007; Swairjo et al.,
2004).
The central theme underlying the association of SepRS and
PylRS with subclass IIc, and with prokaryotic PheRS, lies in the
Table 1. Data Collection and Refinement Statistics
Data Collection
Space group P212121
a, b, c (A˚) 54.9, 90.1, 96.2
a, b, l () 90.0, 90.0, 90.0
Resolution (A˚) 2.2 (2.2)
Rmerge 0.07 (0.44)
<I>/<s(I)> 21.0 (3.3)
Completeness (%) 100(100)
Redundancy 4.4 (3.8)
Refinement
Resolution (A˚) 2.2
No. of reflections 24,973 (1198)
Rwork/Rfree 19.2/24.2
No. atoms
Protein 3353
Ligand 34
Ion 1
Water 221
B-factors
Protein 33.2
Ligand 66.1
Water 42.3
Rmsds
Bond lengths (A˚) 0.00722
Bond angles () 1.260
Data were collected from a single crystal. Values in parentheses are for
highest-resolution shell.ts reserved
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tRNA Triggers Rearrangement of ABD in mitPheRSFigure 1. The Structure of Human mitPheRS
(A) Overall structure of the human mitPheRS enzyme. The N-terminal region (residues 1–47) is depicted in yellow, the catalytic domain (residues 48–289) in blue,
the linker region (residues 290–322) in red, and the C-terminal domain (residues 323–415) in green.
(B) A structure-based sequence alignment of the catalytic domain of human mitPheRS with those of mit yeast, T. thermophilus (PDB code: 1pys), and E. coli
PheRSs. Conserved and similar residues are highlighted in red. The secondary structural elements, as found in the crystal structure of mitPheRS, are indicated
above the sequence alignment. Conserved motifs of class II synthetase are highlighted by boxes.
(C) A structure-based sequence alignment of the C-terminal domain of human mitPheRS. Amino acid residues that participate in specific tRNAPhe anticodon
recognition by T. thermophilus ABD are marked by arrows.fact that all three synthetases resemble each other in the organi-
zation of their catalytic core. The core of (ab)2 T. thermophilus
PheRS is formed by the CAMs from two a subunits and the cat-
alytic-like modules (CLMs) from two large b subunits, which
together comprise a four-helix bundle (Goldgur et al., 1997).
When considered without their peripheral regions, the CAM
and CLM together exhibit an a4-type architecture similar to
that formed by the core domain of homotetrameric SepRS,
and probably that of PylRS as well. This was exemplified byStructure 16superimposing the catalytic core of SepRS onto the CAMs and
CLMs of PheRS: the rmsd between the 525 corresponding Ca
atoms in the two assemblies was found to be 2.2 A˚ (Kamtekar
et al., 2007).
Catalytic domain of human mitPheRS is superimposed onto
the CAM of the bacterial counterpart, with an rmsd of 1.41 A˚
over 193 Ca atoms, and onto the CLM with an rmsd of 1.69 A˚
(Figures 2A and 2C). Superimposition of catalytic core mitPheRS
onto the PylRS and SepRS yields rmsds of 1.5 A˚ (155 Ca atoms), 1095–1104, July 2008 ª2008 Elsevier Ltd All rights reserved 1097
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tRNA Triggers Rearrangement of ABD in mitPheRSand 1.6 A˚ (147Ca atoms), respectively (Figures 2B and 2D). How-
ever, superimposition onto CAM (Figure 2A) also displays con-
formational changes in the portion of the antiparallel b sheet
formed by S8, S9, and S10 strands (see Mosyak et al., 1995).
These changes are due to a concerted twist of three strands
only; the rest of the sheet remains unchanged. Most surprisingly,
the catalytic core of mitPheRS displays a topology, which is re-
markably similar to that of those of PylRS and CLM, but not to
that of SepRS (Figure 2D). Rather, the catalytic core of SepRS
more closely resembles the topology displayed by the CAM of
bacterial PheRS.
Assembly of the CAM and B8* domain supposedly constitutes
the prototype of an active mitochondrial enzyme (Bullard et al.,
1999; Sanni et al., 1991). Superimposing the stand-alone C-ter-
minal domain ofmitPheRS onto the ABDB8 from T. thermophilus
PheRS yields an rmsd of 1.83 A˚ over 80 Ca atoms (Figure 2E).
However, when the catalytic core of the mitochondrial enzyme
is superimposed onto CAM, the C-terminal domain of mitPheRS
turns out to be located elsewhere, far from the ABD’s B8* of
bacterial PheRS (Figure 3A).
Figure 2. Structure Comparison of Human
mitPheRS with Other Class II aaRSs
(A) Superposition of the catalytic core of mitPheRS
and CAM of T. thermophilus (PDB code: 1pys).
MitPheRS is colored blue and CAM is colored red.
(B) Superposition of the catalytic cores of mit-
PheRS and PylRS from Methanosarcina mazei
(PDB code: 2q7e). MitPheRS is colored blue and
PylRS is colored green.
(C) Comparison of the catalytic cores of human
mitPheRS and CLM of T. thermophilus (PDB
code: 1pys). MitPheRS is colored blue and CLM
is colored pink.
(D) Comparison of the catalytic cores of human
mitPheRS and SepRS from Archaeoglobus fulgi-
dus (PDB code: 2du3). MitPheRS is colored blue
and SepRS is colored yellow.
(E) Comparison of the C-terminal domain of hu-
man mitPheRS and the ABD (B8*) of T. thermophi-
lus (PDB code: 1pys). MitPheRS is colored blue
and B8* of T. thermophilus is colored red.
Recognition of Phenylalanyl-
Adenylate
Analysis of the unbiased difference elec-
tron density maps, calculated with the
phases derived from the nearly complete
atomicmodel of mitPheRS, clearly shows
the position of the adenosine ring, phenyl-
alanine, a-phosphate, and that portion of
the electron density that is directed to-
ward the C5* atom of the adenylate
(Figure 4A). Although an electron density
corresponding to the sugar moiety is pre-
sent, it is relativelyweaker, suggesting that
it is the most flexible region of phenyla-
lanyl-adenylate on binding to mitPheRS.
The amino acid binding pocket of
mitPheRS constitutes a deep cavity, as
is also the case in the T. thermophilus enzyme (Fishman et al.,
2001). The surface of the cavity lying parallel to the phenyl ring
of the substrate is covered by the invariant glycines 254, 256,
277, and 279, as well as by invariant hydrophobic Ile93, Leu95,
Phe232, and Phe234. However, one significant structural varia-
tion in this area is observed: Vala261 in the bacterial enzyme is
substituted by Thr235 in mitPheRS.
The anchoring of the a-NH3
+ group of PheAMP is achieved by
direct hydrogen bonding between the Og atom of Ser121 and the
well-ordered water molecule X9 observed in almost all PheRS
complexes (Figure 4A). The X9 molecule, in turn, is located at
an H-bonding distance from the Og of Thr120, the N32 of
Gln157, and the O31 of Glu159 (corresponding to Thra179,
Glna218, and Glua220 in T. thermophilus PheRS). The network
is completed by the interaction of Ser121 with Glu159. The
a-carbonyl oxygen of the substrate forms H bonds with the side
chains of class II invariant Arg 143 (Arga204) and system-con-
served Gln157 (Glna218).
In the bacterial enzyme, an extra hydrogen bond, with
Trpa149 belonging to a ‘‘helical’’ loop (residues 139–152 in1098 Structure 16, 1095–1104, July 2008 ª2008 Elsevier Ltd All rights reserved
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tRNA Triggers Rearrangement of ABD in mitPheRSFigure 3. Docking Model of tRNA Superimposed onto mitPheRS
(A) Comparison of the overall fold and domain arrangement in the human mitPheRS (blue) and T. thermophilus PheRS (red). T. thermophilus PheRS represented
by CAM, B8, and B8* (ABD) domains. Structurally homologous catalytic domains of both PheRSs are presented in the same orientation.
(B) The position of the tRNAPhe is obtained after superimposing the mitochondrial onto the bacterial catalytic domain (1eiy); ‘‘closed conformation.’’ The ABD is
colored pale green, and the tRNA is colored red.
(C) This figure demonstrates that a hinge-type movement (indicated by an arrow) of the mitPheRS C-terminal domain (B8*-like) would be required to reach the
anticodon of tRNAPhe (open conformation).Structure 16, 1095–1104, July 2008 ª2008 Elsevier Ltd All rights reserved 1099
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tRNA Triggers Rearrangement of ABD in mitPheRST. thermophilus PheRS) was detected. In human mitPheRS,
however, this contact is missing for two reasons: (1) an analog
of this loop (formed by residues 96–108) undergoing large con-
formational changes; and (2) variations in amino acid sequences
in this area. The AMP moiety is in stacking interaction with class
II-conserved Phe155. Interaction of the hydrophobic portion of
Arg282 is less pronounced than that seen in bacterial PheRS
complexed with adenylate analogs.
The functional role of the three loops involved in closing up the
active site of PheRS was recently discussed (Moor et al., 2006).
The helical loop of mitPheRS turns off from the adenylate binding
area, significantly widening the entrance to the active site of the
Figure 4. Recognition of Phenylalanyl-
Adenylate
(A) Electron density map of phenylalanyl-adeny-
late in complex with human mitPheRS. The elec-
tron density map is contoured at 2.0s. The protein
residues participating in direct and water-medi-
ated contacts with phenylalanyl-adenylate are
shown. Water molecules are marked by red
spheres.
(B) Comparison of the active site of human mito-
chondrial PheRS, and the catalytic active module
(CAM) of T. thermophilus (PDB code: 1pys).
MitPheRS is colored blue and CAM is colored red.
enzyme (Figure 4B). In contrast, the motif
2 loop (residues 141–155) is shifted by
2.5 A˚ toward the center of the reaction
cavity, as compared with its position in
bacterial PheRS. FPF loops of mitPheRS
and T. thermophilus PheRS (residues
230–238 and 256–264, respectively),
which play a key role in the specific bind-
ing of phenylalanine, show quite similar
conformations.
The Modeling of the mitPheRS-
tRNA Complex
Human mitochondrial aaRS, as well as
other mammalian aaRSs, demonstrate
an ability to aminoacylate tRNAs isolated
from various bacterial and eukaryotic
sources (Sissler et al., 2005). The oppo-
site, however, is not the case: as a rule,
bacterial and cytoplasmic eukaryotic
enzymes are unable to effectively
charge mitochondrial tRNAs. In particu-
lar, human mitPheRS has been shown
to cross-aminoacylate tRNAPhe from
Escherichia coli, T. thermophilus, and
yeast cytoplasm with similar catalytic
efficiency (unpublished data). Multiple
sequence alignment between bacterial
and mitochondrial PheRSs (Figures 1B
and 1C) shows conservation of residues
involved in tRNAPhe recognition.
Experimental evidence of the critical role that the C-terminal
region plays in charging tRNAPhe follows from loss of aminoacy-
lation activity in yeast mitochondrial PheRS when the first 94
amino acid residues from the C terminus are deleted, as well
as from rescuing the G34A mit-tRNAPhe aminoacylation defect
of human mitPheRS by means of mutations at the C terminus
of mitPheRS (Ling et al., 2007; Sanni et al., 1991). Taken to-
gether, these observations suggest that the C-terminal domain
of human mitPheRS functions to bind the tRNAPhe anticodon
loop. Furthermore, mitochondrial yeast PheRS has been shown
to recognize nucleotides fromboth the anticodon and the accep-
tor end (Aphasizhev et al., 1996). The catalytic core of mitPheRS1100 Structure 16, 1095–1104, July 2008 ª2008 Elsevier Ltd All rights reserved
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tRNA Triggers Rearrangement of ABD in mitPheRSsuperimposed onto CAM from PheRS-tRNAPhe complex fits
snugly with the CCA end of T. thermophilus tRNAPhe, the position
of which is rigidly fixed in the active site of CAM. Moreover, func-
tionally important residues are located in close proximity to those
of bacterial PheRS, andmake direct contact with the CCA end of
tRNAPhe (Figures S2A and S2B). The docking model of the C-ter-
minal domain of mitPheRS also fits well with the B8* domain of
the bacterial PheRS. Residues that are involved in the specific
recognition of the tRNAPhe anticodon loop are not only strictly
conserved throughout the amino acid sequences of PheRSs,
but occupy very similar positions in space (Figures S2C and
S2D). Thus, the Tyrb731 involved in a stacking interaction with
G34 substitutes for Phe366, while residues Aspb729 and
Serb742 in T. thermophilus, involved in hydrogen bonding with
G34, display the same capacity in the human mitochondrial
enzyme through the Asp364 and Ser375 residues.
Analysis of the human mitPheRS superimposed onto CAM
from the T. thermophilus PheRS-tRNAPhe complex shows that
the C-terminal domain of mitPheRS and B8* face opposite direc-
tions, and are located far from each other (Figure 3A). More spe-
cifically, the C-terminal domain of mitPheRS interferes with the
acceptor stem of tRNAPhe, as the latter is positioned in the binary
T. thermophilus complex. This finding would suggest that signif-
icant conformational rearrangements are required in order to
place the C-terminal domain of mitPheRS into a position favor-
able to the recognition and binding of the tRNAPhe anticodon
loop. In order for the C-terminal domain and the tRNAPhe antico-
don loop to fit together properly (Figures 3B and 3C), a hinge-
type rotation is required through 160 around an axis parallel
to the motif 1 helix (residues 48–68 in the H1 helix of T. thermo-
philus PheRS). As this takes place, it is reasonably certain that
the CCA end of tRNA remains localized in the active site, as com-
pared with bacterial PheRS. The necessity for conformational
changes is apparent for two reasons: (1) the separation between
A76 (CCA end) and G34 (anticodon loop) in tRNAPhe is about
80 A˚; and (2) the separation between the active site of mitPheRS,
where the CCA end should be located, and the furthest point of
the ABD in its ‘‘closed’’ conformation, is 45 A˚. This suggests
that the size of the mitPheRS in the closed state renders recog-
nition of the anticodon of tRNA impossible, while keeping the
acceptor end of the substrate within the active site.
The three-dimensional isopotential surfaces calculated for dif-
ferent aaRSs at the0.01 kT/e contour level reveal the presence
of large, positive, ‘‘blue’’ patches, one patch for each tRNA mol-
ecule (Tworowski et al., 2005; Tworowski and Safro, 2003). The
presence of ‘‘blue’’ patches at long distances on isopotential
surfaces of electrostatic potential, coupled with the very precise
‘‘footprints’’ of tRNA on the molecular surface (Tworowski et al.,
2005), constitute characteristic features of aaRSs. The long-
range electrostatic complementarity is recognized herein as
the fitting of the homogenous negative potential of tRNA to the
patch of positive potential of aaRS, while availability of the trace
at the van derWaals distances ensures the proper steering of the
CCA end toward the active site.
As it happens, mitPheRS in its ‘‘closed’’ native conformation
fails to exhibit a well-defined electrostatic complementarity to
cognate tRNA on its molecular surface (Figures 5A and 5C).
However, the charge complementarity between mitPheRS and
tRNA may be activated when going from a ‘‘closed’’ to anStructure 16,‘‘open’’ conformation of the enzyme. In its ‘‘open’’ conformation,
an extensive, clearly outlined area of positive surface potential is
revealed (Figures 5B and 5C), which most likely contributes to
recognition of the negatively charged backbone of tRNA. This
finding also suggests that the flexibility of the ABD is essential
to the proper functioning of mitPheRS. When the docked model
of the ‘‘open’’ form of mitPheRS is compared with the binary
T. thermophilus PheRS$tRNAPhe complex, it is apparent that
both the catalytic and the ABDs of mitPheRS approach tRNAs
in an analogous manner.
DISCUSSION
Structure-function analysis of mitPheRS demonstrates that the
class II catalytic domain can operate as a monomer; moreover,
its stabilization via homodimerization or heterodimerization is
not a necessary precondition for its proper function (Cusack,
1995). Significant conformational changes that may directly af-
fect the placement of the substrates in the active site are related
to the rearrangement of the helical loop. While two residues,
Meta148 and Trpa149, directly control the correct placement
Figure 5. Isopotential Surface Representation of mitPheRS
A solvent-accessible surface representation of mitPheRS, colored according
to electrostatic potential (EP) (red for negative and blue for positive) suggests
regions involved in interactions with the negatively charged phosphate back-
bone of the tRNA molecule.
(A) ‘‘Closed’’ conformation.
(B) ‘‘Open’’ conformation.
(C and D) Three-dimensional representation of long-range EP of human mit-
PheRS calculated at the distance ± 0.01 kT/e. Model of complex with tRNAPhe
in ‘‘closed’’ and ‘‘open’’ conformations.1095–1104, July 2008 ª2008 Elsevier Ltd All rights reserved 1101
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tRNA Triggers Rearrangement of ABD in mitPheRSof the substrates in the active site of T. thermophilus PheRS, this
is not necessarily the case inmitPheRS. InmitPheRS, a positively
charged segment of the helical loop formed by Arg102, Lys103,
and Lys104 (Figure 4B) is directed outwards from the Phe-AMP
position, leaving all the side chains exposed to the surface. None
of the residues makes contact with the carbonyl oxygen of the
substrate. Furthermore, the side chains of these residues,
placed in a manner analogous to those of their thermophilic
counterparts, would preclude the placement of the first
intermediate in the active site. Thus, we may conclude that, in
mitPheRS, both phenylalanine activation and the conformational
rearrangement of the 30-terminal portion of cognate tRNAPhe in
the presence of adenylate (if such a rearrangement occurs at
all) may proceed in slightly different structural guidelines.
A remarkable arginine-rich interface has been observed
between the ABD and catalytic domains of mitPheRS. Arginines
located on both sides of these domains form hydrogen bonding
contacts with negatively charged carbonyl oxygens of various
amino acids, as well as with the carboxyl group of Asp347
(Figure S3). Arg144, Arg294, Arg350, and Asn343, all of which
are involved in hydrogen networking at the interface, are strictly
conserved in all known amino acid sequences of eukaryotic mit-
PheRSs. The distinguishing characteristics of the interface to-
pology and internal structure differ significantly in the humanmit-
PheRS and in the T. thermophilusbacterial heterodimer.While, in
the mitochondrial enzyme, the contact area between the two
domains is formedmostly by polar and electrostatic interactions,
in the bacterial enzyme, it essentially depends on hydrophobic
interactions. The significant changes in the interface characteris-
tics indicate that the ‘‘closed’’ conformation of the human mit-
PheRS is not an artifact of the crystallization condition: rather,
it seems to have been designed specifically for functional pur-
poses during evolution. Most likely, the compact ‘‘closed’’ con-
formation is more energetically stable than the extended, more
flexible ‘‘open’’ conformation. The appearance of negatively
charged tRNA (approximately76e) in the vicinity of the polar in-
terface may trigger a decrease in efficiency of the hydrogen
bonding network, with subsequent conformational rearrange-
ment of the C-terminal domain into a position capable of binding
and recognizing the anticodon loop. Thus, tRNA presumably
modulates interactions between the two structural domains, as
well as its own movement toward the binding site.
Several examples of aaRSs in complex with tRNAs, demon-
strating the flexibility of the ABDs, have been described
(Bilokapic et al., 2006; Sauter et al., 2000; Torres-Larios et al.,
2003). The maximum rearrangement of the ABDs between ho-
mologous aaRSs was observed when comparing two SerRSs
isolated frommethanogenic archaea and bacteria. Once the cat-
alytic cores of bothmonomers are aligned in a similar orientation,
a hinge-type movement of about 20 is required to superimpose
their tRNA binding domains (Bilokapic et al., 2006). For human
mitPheRS, the flexibility of the ABD suggests that, upon tRNA
binding, and during the transition to the tRNA-free state, the en-
zyme exhibits both ‘‘open’’ and ‘‘closed’’ conformations. We hy-
pothesize that this global repositioning of the C-terminal domain
bears functional loads, and constitutes an inherent property of
monomeric mitPheRS. However, the possibility that two equiva-
lent ‘‘open’’ and ‘‘closed’’ conformations exist in solution cannot
be ruled out.1102 Structure 16, 1095–1104, July 2008 ª2008 Elsevier Ltd All rightHuman mitPheRS, as well as other mammalian mitochondrial
enzymes, are less efficient than the corresponding E. coli en-
zymes in aminoacyl-adenylate formation (Florentz and Sissler,
2003). In human mitPheRS, the kcat/KM for the Phe substrate de-
termined from ATP:PPi exchange kinetics is 100-fold lower than
that observed in the bacterial PheRS (Bullard et al., 1999). It is
important to note how the structural variations in the active site
of human mitPheRS exert control over catalytic efficiency, as
compared to its bacterial homolog. Specific recognition of the
phenylalanine portion of Phe-AMP in both mitochondrial and
bacterial enzymes is achieved by interactions of the substrate
phenyl ring with the side chains of two neighboring residues,
Phe232 and Phe234 (Phea258 and Phea260 in T. thermophilus
bacterial PheRS), thereby forming a ‘‘network’’ of interactions,
such that each aromatic pair is arranged in accordance with
‘‘edge-to-face’’ contacts. Thus, for PheRSs containing aromatic
amino acid residues at the same relative positions, similar affin-
ities for the phenylalanine substrate may be expected. Conse-
quently, the lesser catalytic efficiency of interaction with phenyl-
alanine in humanmitPheRS is due to the lower specific activity of
the enzyme (kcat). Such is indeed the case for the reported kinetic
constants (Bullard et al., 1999).
It is known that bacterial PheRS demonstrates a marked de-
gree of natural plasticity within the active site: the amino acid
binding pocket is capable of binding both the noncognate tyro-
sine and an unnatural derivative, p-Cl phenylalanine; i.e., sub-
strates larger than the cognate phenylalanine (Kotik-Kogan
et al., 2005). The appearance of a hydroxyl-containing Thr235
at the bottom of the mitPheRS amino acid binding pocket lends
additional credence to the notion of plasticity in PheRS’s active
site. Both bacterial and eukaryotic cytoplasmic PheRSs have
been shown to misactivate the noncognate L-tyrosine (Kotik-
Kogan et al., 2005; Roy et al., 2004; Sasaki et al., 2006). Yeast
mitPheRS also misactivates L-tyrosine, although its selectivity is
one order of magnitude higher than that of yeast cytosolic PheRS
(Roy et al., 2005). However, yeast mitPheRS is unable to deacy-
late Tyr-tRNAPhe due to the absence of the editing module asso-
ciated with domains B3/B4 (Roy et al., 2005). A similar observa-
tion has been made regarding human mitPheRS, which also
lacks an editing function against the misaminoacylated Tyr-
tRNAPhe (Ling et al., 2007). Furthermore, no trans editing has
been detected inmitochondrial extracts, indicating that the qual-
ity control of protein synthesis normally gained by proofreading
Tyr-tRNAPhe is missing from mitochondria (Roy et al., 2005).
At least seven different pathogenic point mutations in human
mitochondrial tRNAPhe have been reported (Zifa et al., 2007).
Biochemical analysis suggests that the original pathogenic mu-
tations in human mitochondrial tRNAPhe decrease the levels of
aminoacylation activity by affecting the global or local tRNA
structure (Ling et al., 2007). However, pathogenic mutations
within the anticodon loop of mitochondrial tRNAs are rare.
Thus far, only two mutations within the anticodon triplet of mito-
chondrial tRNAs have been described (Zifa et al., 2007). The
G34A pathogenic mutation in human mitochondrial tRNAPhe is
associated with myoclonic epilepsy associated with ragged-
red fibers (MERRF) syndrome, a rare, serious muscular disorder
caused by a defect in the genetic material arising from the mito-
chondria (Ling et al., 2007). The nucleotide G34 is a well-charac-
terized identity element for both bacterial and cytoplasmics reserved
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tRNA Triggers Rearrangement of ABD in mitPheRStRNAPhes (Safro et al., 2005); however, it is not thought to serve
as a structural element in which mutation would lead to signifi-
cant changes in the three-dimensional structure of the molecule.
The severe loss in aminoacylation efficiency indicates that G34
also serves as an identity element for mitochondrial PheRS. In-
deed, residues of T. thermophilus PheRS participating in the
specific recognition of G34within the anticodon loop, comprised
of tRNAPhe, Aspb729 (Asp364), Serb742 (Ser375), and Argb780
(Arg414), are markedly conserved among bacterial and mito-
chondrial PheRSs. In an attempt to rescue the aminoacylation
defect of the G34A tRNAPhe mutation, the nucleus-encoded hu-
man mitPheRS was rationally modified with the T. thermophilus
PheRS$tRNAPhe cocrystal structure as a model (Goldgur et al.,
1997; Ling et al., 2007). The resulting enzyme variants showed
significantly improved aminoacylation efficiency for the G34A
mutant, suggesting a potential route to treat this presentation
of MERRF syndrome. However, when considering double and
triple mutations in mitPheRS that restore its activity to the wild-
type level or higher, the van der Waals contacts in this area
should be taken into account. Thus, in the T. thermophilus en-
zyme, a van der Waals contact of Alab*698 with the A35 base
plays an important role, because any side chain of greater length
(instead of the conserved Ala) would interfere with the anticodon
base. In the mitochondrial enzyme, Ala is substituted for Ser699
in this position. Further improvements in the activity of the mito-
chondrial PheRS may be expected, based on the structural data
of mitPheRS complexed with wild-type and mutant variants of
tRNAPhe.
EXPERIMENTAL PROCEDURES
Protein Purification, Crystallization, and Structure Determination
Crystallization of mitPheRS was carried out as previously described (Levin
et al., 2007). For data collection at cryogenic temperatures (100K), mitPheRS
crystals were transferred to a mother liquor solution containing 25% glycerol,
then flash frozen andmounted on a cryogenic loop (Teng, 1990) with anOxford
Cryostream (Cosier and Glaser, 1986) low-temperature device. A complete
X-ray data set to 2.2 A˚ was collected from a single crystal on a Rigaku
R-AXIS IV2+ imaging plate area detector mounted on a Rigaku RU-H3R rotat-
ing anode equipped with a multilayer focusing mirror from OSMIC and Cu
X-ray radiation (l = 1.5418 A˚). The diffraction data were integrated, scaled,
and reduced with the HKL-2000 program package (Otwinowski and Minor,
1997). The mitPheRS structure was solved by the molecular replacement
method implemented in PHASER crystallographic software (McCoy, 2007).
The crystal structure of bacterial PheRS from T. thermophilus (PDB code:
1pys) was utilized as the search model. A partial model of mitPheRS was
rebuilt manually with the O (Jones et al., 1991) and COOT (Emsley andCowtan,
2004) programs. Refinement of the structure was carried out with a combina-
tion of CNS (Brunger et al., 1998), REFMAC5 (Murshudov et al., 1997), and
RESOLVE (Terwilliger, 2003) program packages. The completeness of the
model was brought up to 90% by using ARP/wARP (Perrakis et al., 1999)
software. The refinement of the model with CNS was alternated with the man-
ual revision of the model in COOT and O. The refined model contains 405
residues; residues 1–10 were excluded from the model because of poor elec-
tron density. R and Rfree values were 20% and 24%, respectively (see Table 1
for refinement statistics). All molecular graphic figures were generated with
PyMOL (http://pymol.sourceforge.net) and UCSF Chimera (Pettersen et al.,
2004).
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